Suppr超能文献

逐瘀丸通过调节p53/SLC7A11信号通路介导的氧化损伤和铁死亡来治疗动脉粥样硬化

[Zhuyu Pills regulate p53/SLC7A11 signaling pathway-mediated oxidative damage and ferroptosis to treat atherosclerosis].

作者信息

Song Wei, Zhang Zhong-Yi, Zhang Xiao-Bo, Shen Tao

机构信息

Chengdu University of Traditional Chinese Medicine Chengdu 610075, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2024 Aug;49(15):4118-4127. doi: 10.19540/j.cnki.cjcmm.20240401.401.

Abstract

This article aims to investigate the effect of Zhuyu Pills on atherosclerosis(AS) and decipher the underlying mechanism. The mouse model of AS was established by feeding with a high-fat diet for 12 weeks. The 50 successfully modeled mice with the apolipoprotein E knockout(ApoE(-/-)) were assigned by the random number table method into 5 groups(n=10): model, low-, medium-, and high-dose(130.54, 261.08, 522.16 mg·kg(-1), respectively) Zhuyu Pills, and atorvastatin calcium(10.40 mg·kg~(-1)). Ten C57BL/6J mice were selected as the blank group. The blank group and model group were administrated with an equal volume of normal saline, and other groups were administrated with corresponding drugs once a day for 12 weeks. At the end of drug intervention, hematoxylin-eosin(HE) staining was employed to observe the pathological changes of fat in the aorta, liver, and epididymis of mice, and the proportion of aortic plaque area, fat area in epididymis, and nonalcoholic fatty liver disease activity score(NAS) were calculated. Lipid and collagen deposition in the aorta was observed by oil red O staining and Masson staining, respectively, and the proportions of lipid and collagen deposition areas were calculated. The serum levels of superoxide dismutase(SOD), malondialdehyde(MDA), glutathione peroxidase(GSH-Px), and iron ion were measured by colorimetry. The expression of cyclooxygenase 2(COX2), ferritin heavy chain 1(FTH1), cystine/glutamate reverse transporter solute carrier family 7 member 11(SLC7A11), and glutathione peroxidase 4(GPX4) in the aorta was detected by the immunofluorescence assay. The level of tumor protein 53(p53) in the aorta was detected by immunohistochemistry. The protein levels of p53 and SLC7A11 in the aorta were determined by Western blot. The mRNA levels of p53, SLC7A11, GPX4, FTH1, prostaglandin G/H synthase 2(PTGS2), and reduced nicotinamide adenine dinucleotide phosphate oxidase 1(NOX1) in mouse aorta were determined by real-time PCR. The results showed that compared with the blank group, the model group showcased enlarged aortic plaque area, increased collagen fiber deposition, liver lipid deposition, and lipid droplets, and enlarged epididymal adipocytes. In addition, the modeling elevated the levels of iron ion and MDA and lowered the levels of SOD and GSH-Px in the serum, promoted the expression of p53 and COX2, down-regulated the protein and mRNA levels of FTH1, SLC7A11, and GPX4, and up-regulated the mRNA levels of PTGS2 and NOX1 in the aorta. Compared with the model group, low-, medium-, and high-dose Zhuyu Pills and atorvastatin calcium reduced the aortic plaque area, collagen deposition, liver lipid deposition, lipid droplets, and epididymal adipocyte volume, lowered the levels of iron ion and MDA and elevated the levels of SOD and GSH-Px in the serum, inhibited the expression of p53 and COX2, up-regulated the protein and mRNA levels of FTH1, SLC7A11, and GPX4, and down-regulated the mRNA levels of PTGS2 and NOX1 in the aorta. In conclusion, Zhuyu Pills exert definite therapeutic effect on aortic plaque in AS mice by regulating the p53/SLC7A11 signaling pathway to alleviate oxidative damage and inhibit ferroptosis.

摘要

本文旨在研究逐瘀丸对动脉粥样硬化(AS)的影响并阐明其潜在机制。通过高脂饮食喂养12周建立AS小鼠模型。将50只成功建模的载脂蛋白E基因敲除(ApoE(-/-))小鼠按随机数字表法分为5组(n = 10):模型组、低、中、高剂量逐瘀丸组(分别为130.54、261.08、522.16 mg·kg(-1))和阿托伐他汀钙组(10.40 mg·kg~(-1))。选取10只C57BL/6J小鼠作为空白组。空白组和模型组给予等体积生理盐水,其他组每天给予相应药物,连续12周。在药物干预结束时,采用苏木精-伊红(HE)染色观察小鼠主动脉、肝脏和附睾脂肪的病理变化,并计算主动脉斑块面积、附睾脂肪面积和非酒精性脂肪性肝病活动评分(NAS)的比例。分别采用油红O染色和Masson染色观察主动脉脂质和胶原沉积情况,并计算脂质和胶原沉积面积的比例。采用比色法测定血清中超氧化物歧化酶(SOD)、丙二醛(MDA)、谷胱甘肽过氧化物酶(GSH-Px)和铁离子水平。采用免疫荧光法检测主动脉中环氧化酶2(COX2)、铁蛋白重链1(FTH1)、胱氨酸/谷氨酸逆向转运体溶质载体家族7成员11(SLC7A11)和谷胱甘肽过氧化物酶4(GPX4)的表达。采用免疫组织化学法检测主动脉中肿瘤蛋白53(p53)水平。采用蛋白质印迹法测定主动脉中p53和SLC7A11的蛋白水平。采用实时荧光定量PCR法测定小鼠主动脉中p53、SLC7A11、GPX4、FTH1、前列腺素G/H合酶2(PTGS2)和还原型烟酰胺腺嘌呤二核苷酸磷酸氧化酶1(NOX1)的mRNA水平。结果显示,与空白组相比,模型组主动脉斑块面积增大、胶原纤维沉积增加、肝脏脂质沉积和脂滴增多、附睾脂肪细胞增大。此外,建模使血清中铁离子和MDA水平升高,SOD和GSH-Px水平降低,促进p53和COX2表达,下调主动脉中FTH1、SLC7A11和GPX4的蛋白及mRNA水平,上调PTGS2和NOX1的mRNA水平。与模型组相比,低、中、高剂量逐瘀丸和阿托伐他汀钙可减小主动脉斑块面积、胶原沉积、肝脏脂质沉积、脂滴和附睾脂肪细胞体积,降低血清中铁离子和MDA水平,升高SOD和GSH-Px水平,抑制p53和COX2表达,上调主动脉中FTH1、SLC7A11和GPX4的蛋白及mRNA水平,下调PTGS2和NOX1的mRNA水平。综上所述,逐瘀丸通过调节p53/SLC7A11信号通路减轻氧化损伤并抑制铁死亡,对AS小鼠主动脉斑块具有确切的治疗作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验